OverStitch NXT ™ NeXT Generation Single Channel Endoscopic System
The OverStitch NXT Endoscopic system may enable physicians to manage complications in therapeutic gastroenterology procedures and may provide patients with endoscopic treatment options in place of traditional surgery.* OverStitch NXT is an endoscopic suturing system designed for use on Single Channel gastroscopes. Compatibility with a wide range of gastroscopes across multiple manufactures may minimize the need for investments in new capital equipment.
Transforming therapeutic endoscopy
The technology and design behind this suturing system is what makes it a top choice for physicians across the world.
Product Features & Benefits
Full Thickness Endoscopic Suturing Tissue approximation for defect closure in therapeutic endoscopic procedures.
Advanced Scope Retroflexion MaxFlex enhances single-channel scope flexibility up to 210° facilitating access to difficult-to-reach anatomy.
Physician Controlled Tissue Acquisition Option Tissue Helix Pro™ enables full physician control of tissue acquisition and suturing.
Ordering Information
| SKU | Description | Pkg Qty |
|---|---|---|
| ESS-G02-NXT | OverStitch NXT™ Endoscopic Suturing System | 3 |
| NXT-THXP-130 | OverStitch NXT™ Tissue Helix Pro | 6 |
| PLY-G02-020-APL | OverStitch™ 2-0 Polypropylene Suture | 12 |
| CNH-G01-000 | OverStitch™ Suture Cinch | 6 |
| OVT‐027‐160 | OverTube™ Endoscopic Access System | 3 |
| ES26165-3 | Ensizor™ Endoscopic Scissors - 165cm | 3 |
| ESS-ESG-NXT | OverStitch NXT Endoscopic Suturing System | 1 |
*R Maselli et al. Endoscopic suturing for GI applications: initial results from a prospective multicenter European registry, Gastrointestinal Endoscopy, Volume 96, Issue 5, 2022, Pages 780-786.
As a condition of the FDA De Novo Authorization of the Overstitch NXT and Overstitch Endoscopic Suturing System for endobariatric procedures (formerly referred to as the Apollo ESG and Apollo REVISE Systems), the devices should only be used for Endoscopic Sleeve Gastroplasty (ESG) or to enable transoral outlet reduction (TORe) as a bariatric revision procedure by gastroenterologists and surgeons who have undergone specific training by the device manufacturer.
To fulfill the FDA requirement and special controls for these devices, Boston Scientific is required to independently host courses with consistent training curricula. More information regarding the referenced ESG and TORe revision procedure training courses is available through Boston Scientific.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
